Rhythm Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	174.33	130.13	77.43	23.64	3.15	-	Upgrade
Revenue Growth (YoY)	54.92%	68.06%	227.56%	649.46%	-	-	Upgrade
Cost of Revenue	18.48	13.37	9.3	2.13	0.6	-	Upgrade
Gross Profit	155.86	116.76	68.13	21.51	2.56	-	Upgrade
Selling, General & Admin	175.59	144.3	117.53	92.03	68.49	46.13	Upgrade
Research & Development	166.48	237.96	134.95	108.63	104.13	90.45	Upgrade
Operating Expenses	342.07	382.26	252.48	200.66	172.61	136.58	Upgrade
Operating Income	-186.21	-265.5	-184.36	-179.16	-170.06	-136.58	Upgrade
Interest Expense	-21.42	-20.6	-13.89	-5.2	-	-	Upgrade
Interest & Investment Income	14.72	14.71	13.95	4.03	0.45	2.58	Upgrade
Other Non Operating Income (Expenses)	9.91	11.14	0.19	0.25	100	-	Upgrade
EBT Excluding Unusual Items	-182.99	-260.26	-184.11	-180.08	-69.61	-134	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-1.04	-	-	Upgrade
Pretax Income	-191.89	-260.26	-184.11	-181.12	-69.61	-134	Upgrade
Income Tax Expense	0.44	0.35	0.56	-	-	-	Upgrade
Net Income	-192.33	-260.6	-184.68	-181.12	-69.61	-134	Upgrade
Preferred Dividends & Other Adjustments	5.39	3.97	-	-	-	-	Upgrade
Net Income to Common	-197.71	-264.57	-184.68	-181.12	-69.61	-134	Upgrade
Shares Outstanding (Basic)	64	61	58	52	50	44	Upgrade
Shares Outstanding (Diluted)	64	61	58	52	50	44	Upgrade
Shares Change (YoY)	5.39%	5.76%	10.65%	5.08%	12.40%	21.15%	Upgrade
EPS (Basic)	-3.11	-4.34	-3.20	-3.47	-1.40	-3.04	Upgrade
EPS (Diluted)	-3.11	-4.34	-3.20	-3.47	-1.40	-3.04	Upgrade
Free Cash Flow	-109.13	-113.88	-136.2	-173.71	-146.44	-122.19	Upgrade
Free Cash Flow Per Share	-1.71	-1.87	-2.36	-3.33	-2.95	-2.77	Upgrade
Gross Margin	89.40%	89.73%	87.99%	90.98%	81.01%	-	Upgrade
Operating Margin	-106.81%	-204.04%	-238.10%	-757.92%	-5391.85%	-	Upgrade
Profit Margin	-113.41%	-203.32%	-238.52%	-766.22%	-2207.10%	-	Upgrade
Free Cash Flow Margin	-62.60%	-87.51%	-175.91%	-734.87%	-4642.90%	-	Upgrade
EBITDA	-184.76	-263.94	-182.6	-177.49	-168.9	-135.89	Upgrade
EBITDA Margin	-105.98%	-202.83%	-235.83%	-	-	-	Upgrade
D&A For EBITDA	1.45	1.56	1.76	1.67	1.16	0.69	Upgrade
EBIT	-186.21	-265.5	-184.36	-179.16	-170.06	-136.58	Upgrade
EBIT Margin	-106.81%	-204.04%	-238.10%	-	-	-	Upgrade
Revenue as Reported	174.33	130.13	77.43	23.64	3.15	-	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q